Evidence map›Paper›PMID 42662109›Full record

ArticleMDM policy & practice

Estimating Chronic Kidney Disease Stage Transitions from Irregular Electronic Health Record Data Using an Expectation-Maximization Framework.

Wendy Qi, Jennifer Mason Lobo, Guofen Yan, Rahwa Ghenbot, Kenneth G Sands, Tracey L Krupski, Stephen H Culp, Daniel F Otero-León

Abstract read
In one paragraph

Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wendy QiDepartment of Systems and Information Engineering, University of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0009-0000-9655-1285
Jennifer Mason LoboDepartment of Systems and Information Engineering, University of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0001-8375-2475
Guofen YanDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0003-1150-4899
Rahwa GhenbotDepartment of Urology, University of Virginia School of Medicine, Charlottesville, VA, USA.ORCID https://orcid.org/0009-0009-9354-6400
Kenneth G SandsDepartment of Urology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Tracey L KrupskiDepartment of Urology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Stephen H CulpDepartment of Urology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Daniel F Otero-LeónDepartment of Systems and Information Engineering, University of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0003-2404-1635

Funding

Optimizing Treatment Decision Making for Patients with Localized Renal MassR01CA284057 · NCI · UNIVERSITY OF VIRGINIA · PI Stephen Hembree Culp, Jennifer Mason Lobo · 2023 to 2026
$1.5M
NCI NIH HHS R01 CA284057
6 · The paper itself

Abstract

Objective: To estimate chronic kidney disease (CKD) stage transition probabilities in patients with small renal masses (SRMs) using irregularly observed electronic health record (EHR) data, addressing challenges of interval censoring and irregular measurement intervals in real-world clinical practice. Data Sources: We used EHR data from the institutional Small Renal Mass registry (2006-January 2026), capturing outpatient renal function data prior to any definitive treatment for SRM. CKD stages were defined using estimated glomerular filtration rate (eGFR) thresholds based on KDIGO guidelines. Study Design: The final analytic cohort included 527 patients with at least 2 outpatient eGFR measurements prior to definitive treatment. We applied an expectation-maximization (EM) algorithm to estimate discrete-time CKD stage transition matrices while accounting for irregular eGFR measurement intervals and unobserved intermediate transitions. Transition matrices were estimated under 3- and 6-mo cycle lengths overall as well as stratified by age and sex. The likelihood ratio statistic was used to compare EM-based estimates with the empirical counting estimator. Results: The EM framework yielded clinically plausible transition structures dominated by self-transitions and progression primarily to adjacent CKD stages, with reduced spurious backward transitions relative to the empirical estimator. Transition patterns were consistent across 3- and 6-mo cycle lengths. Age-stratified analyses showed that older patients had slightly higher probabilities of progression to more advanced CKD stages compared with younger patients, whereas sex-stratified differences were minimal. Likelihood ratio comparisons supported the consistency of the EM-based models with the observed transition data in both the overall cohort and subgroup analyses. Conclusions: The EM approach provides a principled and computationally efficient method for estimating CKD stage progression from irregularly observed EHR data, yielding transition matrices suitable for discrete-time decision-analytic and health economic models.

Indexed as

chronic kidney diseasedecision modelingdisease progressionexpectation–maximization algorithm

Identifiers

PMID42662109
PMCPMC13519163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.